Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2180995rdf:typepubmed:Citationlld:pubmed
pubmed-article:2180995lifeskim:mentionsumls-concept:C0025266lld:lifeskim
pubmed-article:2180995lifeskim:mentionsumls-concept:C0162311lld:lifeskim
pubmed-article:2180995lifeskim:mentionsumls-concept:C1522577lld:lifeskim
pubmed-article:2180995lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:2180995lifeskim:mentionsumls-concept:C0717924lld:lifeskim
pubmed-article:2180995pubmed:issue4lld:pubmed
pubmed-article:2180995pubmed:dateCreated1990-5-10lld:pubmed
pubmed-article:2180995pubmed:abstractTextThirty-one men with androgenetic alopecia completed 4 1/2 to 5 years of therapy with 2% and 3% topical minoxidil. Hair regrowth with topical minoxidil tended to peak at 1 year with a slow decline in regrowth over subsequent years. However, at 4 1/2 to 5 years, maintenance of nonvellus hairs beyond that seen at baseline was still evident. Topical minoxidil appears to be effective in helping to maintain nonvellus hair growth in men with androgenetic alopecia.lld:pubmed
pubmed-article:2180995pubmed:languageenglld:pubmed
pubmed-article:2180995pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2180995pubmed:citationSubsetIMlld:pubmed
pubmed-article:2180995pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2180995pubmed:statusMEDLINElld:pubmed
pubmed-article:2180995pubmed:monthAprlld:pubmed
pubmed-article:2180995pubmed:issn0190-9622lld:pubmed
pubmed-article:2180995pubmed:authorpubmed-author:AmaraI AIAlld:pubmed
pubmed-article:2180995pubmed:authorpubmed-author:WeinerM SMSlld:pubmed
pubmed-article:2180995pubmed:authorpubmed-author:OlsenE AEAlld:pubmed
pubmed-article:2180995pubmed:authorpubmed-author:DeLongE RERlld:pubmed
pubmed-article:2180995pubmed:issnTypePrintlld:pubmed
pubmed-article:2180995pubmed:volume22lld:pubmed
pubmed-article:2180995pubmed:ownerNLMlld:pubmed
pubmed-article:2180995pubmed:authorsCompleteYlld:pubmed
pubmed-article:2180995pubmed:pagination643-6lld:pubmed
pubmed-article:2180995pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:2180995pubmed:meshHeadingpubmed-meshheading:2180995-...lld:pubmed
pubmed-article:2180995pubmed:meshHeadingpubmed-meshheading:2180995-...lld:pubmed
pubmed-article:2180995pubmed:meshHeadingpubmed-meshheading:2180995-...lld:pubmed
pubmed-article:2180995pubmed:meshHeadingpubmed-meshheading:2180995-...lld:pubmed
pubmed-article:2180995pubmed:meshHeadingpubmed-meshheading:2180995-...lld:pubmed
pubmed-article:2180995pubmed:meshHeadingpubmed-meshheading:2180995-...lld:pubmed
pubmed-article:2180995pubmed:meshHeadingpubmed-meshheading:2180995-...lld:pubmed
pubmed-article:2180995pubmed:meshHeadingpubmed-meshheading:2180995-...lld:pubmed
pubmed-article:2180995pubmed:meshHeadingpubmed-meshheading:2180995-...lld:pubmed
pubmed-article:2180995pubmed:meshHeadingpubmed-meshheading:2180995-...lld:pubmed
pubmed-article:2180995pubmed:year1990lld:pubmed
pubmed-article:2180995pubmed:articleTitleFive-year follow-up of men with androgenetic alopecia treated with topical minoxidil.lld:pubmed
pubmed-article:2180995pubmed:affiliationDepartment of Medicine, Duke University Medical Center, Durham, NC 27710.lld:pubmed
pubmed-article:2180995pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2180995pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2180995pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:2180995pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2180995lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2180995lld:pubmed